FI924674A0 - En foerbaettrad process foer framstaellning av substituerade indolanderivat - Google Patents

En foerbaettrad process foer framstaellning av substituerade indolanderivat

Info

Publication number
FI924674A0
FI924674A0 FI924674A FI924674A FI924674A0 FI 924674 A0 FI924674 A0 FI 924674A0 FI 924674 A FI924674 A FI 924674A FI 924674 A FI924674 A FI 924674A FI 924674 A0 FI924674 A0 FI 924674A0
Authority
FI
Finland
Prior art keywords
pct
compound
date oct
framework
substances
Prior art date
Application number
FI924674A
Other languages
English (en)
Other versions
FI101148B (fi
FI924674A (fi
Inventor
Robert Giles
Timothy Charles Walsgrove
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of FI924674A0 publication Critical patent/FI924674A0/fi
Publication of FI924674A publication Critical patent/FI924674A/fi
Priority to FI960929A priority Critical patent/FI102533B1/fi
Application granted granted Critical
Publication of FI101148B publication Critical patent/FI101148B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/40—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups and esterified hydroxy groups bound to acyclic carbon atoms of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78—Benzoic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI924674A 1990-04-17 1992-10-15 Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote FI101148B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI960929A FI102533B1 (fi) 1990-04-17 1996-02-28 4-(2'-substituoidut etyyli)-1,3-dihydro-2H-indol-2-oniyhdisteet

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909008605A GB9008605D0 (en) 1990-04-17 1990-04-17 Process
PCT/GB1991/000587 WO1991016306A1 (en) 1990-04-17 1991-04-15 An improved process for the preparation of substituted indolone derivatives

Publications (3)

Publication Number Publication Date
FI924674A0 true FI924674A0 (fi) 1992-10-15
FI924674A FI924674A (fi) 1992-10-15
FI101148B FI101148B (fi) 1998-04-30

Family

ID=10674534

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924674A FI101148B (fi) 1990-04-17 1992-10-15 Parannettu menetelmä 4-£2-(di-n-propyyliamino)etyyli|-1,3-dihydro-2H-i ndol-2-onin valmistamiseksi ja uusi välituote

Country Status (29)

Country Link
US (1) US5336781A (fi)
EP (1) EP0526529B1 (fi)
JP (2) JP2788548B2 (fi)
KR (1) KR0180215B1 (fi)
CN (1) CN1027892C (fi)
AP (1) AP184A (fi)
AT (1) ATE144251T1 (fi)
AU (2) AU640006B2 (fi)
CA (1) CA2080221C (fi)
CY (1) CY1981A (fi)
DE (1) DE69122753T2 (fi)
DK (1) DK0526529T3 (fi)
ES (1) ES2094812T3 (fi)
FI (1) FI101148B (fi)
GB (1) GB9008605D0 (fi)
GR (1) GR3022261T3 (fi)
HK (1) HK3097A (fi)
HU (1) HU214822B (fi)
IE (1) IE911262A1 (fi)
IL (7) IL97867A (fi)
MA (1) MA22133A1 (fi)
MY (1) MY109628A (fi)
NO (2) NO178396C (fi)
NZ (1) NZ237819A (fi)
PL (1) PL166736B1 (fi)
PT (1) PT97375B (fi)
SA (1) SA91110352B1 (fi)
WO (1) WO1991016306A1 (fi)
ZA (1) ZA912782B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process
DK0547165T3 (da) * 1990-09-28 2000-03-27 Smithkline Beecham Corp Fremgangsmåde til fremstilling af vandopløselige camptothecinanaloger såvel som forbindelserne 10-hydroxy-11-C(1-6)-alkoxyc
GB9300309D0 (en) * 1993-01-08 1993-03-03 Smithkline Beecham Plc Process
US6218421B1 (en) * 1999-07-01 2001-04-17 Smithkline Beecham P.L.C. Method of promoting smoking cessation
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
WO2005074387A2 (en) * 2003-12-30 2005-08-18 Sun Pharmaceutical Industries Limited Novel crystal forms of 4-[2-di-n-propylamino)ethyl]-2 (3h)- indolone hydrochloride
US7378439B2 (en) * 2004-01-20 2008-05-27 Usv, Ltd. Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride
WO2005105741A1 (en) * 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
WO2005080333A1 (en) * 2004-02-19 2005-09-01 Torrent Pharmaceuticals Ltd Process for purification of ropinirole
US20070254941A1 (en) * 2006-04-21 2007-11-01 Glenmark Pharmaceuticals Limited Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
CN103130704B (zh) * 2013-03-11 2019-03-22 上海奥博生物医药技术有限公司 一种制备4-(2-羟乙基)-1，3-二氢-2h-吲哚-2-酮的新方法
CN103145604A (zh) * 2013-03-19 2013-06-12 上海奥博生物医药技术有限公司 一种制备罗匹尼罗关键中间体的方法
CN105418482A (zh) * 2015-11-23 2016-03-23 东南大学 一种改进的盐酸罗匹尼罗的制备方法
CN108440376B (zh) * 2018-05-08 2020-06-05 中国科学院成都生物研究所 一种盐酸罗匹尼罗的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154976A (en) * 1967-02-21 1969-06-11 Pfizer Ltd N-Phenyl Indoline Derivatives
JPS53101333A (en) * 1977-02-14 1978-09-04 Sagami Chem Res Center 3-acyloxymethyl-3,4:5,6-diepoxycyclohexane-1,2-diol and
IT1171624B (it) * 1980-11-12 1987-06-10 Thomae Gmbh Dr K Indolinoni dotati di proprieta' farmaceutiche e procedimento per la loro produzione
US4588790A (en) * 1982-03-24 1986-05-13 Union Carbide Corporation Method for fluidized bed polymerization
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US4593033A (en) * 1985-04-24 1986-06-03 Merck & Co., Inc. Substituted indeno[2,1-c] pyridines useful as calcium channel blockers
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
GB8714371D0 (en) * 1987-06-19 1987-07-22 Smith Kline French Lab Process
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB9008605D0 (en) * 1990-04-17 1990-06-13 Smith Kline French Lab Process

Also Published As

Publication number Publication date
AU646771B2 (en) 1994-03-03
JPH10251205A (ja) 1998-09-22
AP9100251A0 (en) 1991-04-30
IL111028A (en) 1995-11-27
JPH05506029A (ja) 1993-09-02
CN1056686A (zh) 1991-12-04
AU7656291A (en) 1991-11-11
MY109628A (en) 1997-03-31
CY1981A (en) 1997-09-05
IL111030A (en) 1995-11-27
DK0526529T3 (da) 1996-11-18
DE69122753D1 (de) 1996-11-21
NO178396C (no) 1996-03-20
ATE144251T1 (de) 1996-11-15
CA2080221A1 (en) 1991-10-18
HUT64742A (en) 1994-02-28
CN1027892C (zh) 1995-03-15
JP3044013B2 (ja) 2000-05-22
MA22133A1 (fr) 1991-12-31
PT97375B (pt) 1998-08-31
HU214822B (hu) 1998-06-29
HU9203261D0 (en) 1992-12-28
NO178396B (no) 1995-12-11
PL166736B1 (pl) 1995-06-30
AP184A (en) 1992-06-30
IL97867A (en) 1995-11-27
NO1999012I1 (no) 1999-06-18
IL111030A0 (en) 1994-11-28
FI101148B (fi) 1998-04-30
IL111028A0 (en) 1994-11-28
FI924674A (fi) 1992-10-15
HK3097A (en) 1997-01-10
IL111029A (en) 1995-11-27
KR0180215B1 (ko) 1999-03-20
IL97867A0 (en) 1992-06-21
IL111029A0 (en) 1994-11-28
CA2080221C (en) 2000-11-14
NO924028D0 (no) 1992-10-16
DE69122753T2 (de) 1997-05-07
AU3566993A (en) 1993-06-03
AU640006B2 (en) 1993-08-12
ZA912782B (en) 1992-11-25
EP0526529B1 (en) 1996-10-16
SA91110352B1 (ar) 2001-11-12
WO1991016306A1 (en) 1991-10-31
GB9008605D0 (en) 1990-06-13
ES2094812T3 (es) 1997-02-01
GR3022261T3 (en) 1997-04-30
NO924028L (no) 1992-10-16
US5336781A (en) 1994-08-09
PT97375A (pt) 1992-01-31
IE911262A1 (en) 1991-10-23
NZ237819A (en) 1993-05-26
EP0526529A1 (en) 1993-02-10
JP2788548B2 (ja) 1998-08-20

Similar Documents

Publication Publication Date Title
FI924674A (fi) En foerbaettrad process foer framstaellning av substituerade indolanderivat
EE03194B1 (et) Ühendid, nende kasutamine magustavate toimeainetena ja nende valmistamise meetod
NO178764C (no) Fremgangsmåte ved fremstilling av oksetanoner
EA199801000A1 (ru) Производные алкиламинобензотиазола и -бензоксазола
DK400781A (da) Fremgangsmaade til fremstilling af 2-(1,4-benzodioxan-2-ylalkyl) imidazoler
EA199600007A2 (ru) Новые трициклические производные, способ их получения, способы получения оптически активных или рацемических колхицина и тиоколхицина, их аналогов или производных с использованием трициклических соединений и промежуточные продукты синтеза
DK42587D0 (da) Fremgangsmaade til fremstilling af piperidinylcyklo-pentylheptensyre-derivater og salte deraf
GB1441941A (en) Process for the preparation of 5-substituted resorcinols and related intermediates
FR2737207B1 (fr) Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique
ATE27955T1 (de) Verfahren und zwischenprodukte zur herstellung von 2-substituierten 4-acetyl-imidazolen.
ES2001701A6 (es) Un metodo para preparar compuesto de benzoilurea
ATE17000T1 (de) Substituierte azolylethyl-oximinoalkyl-ether, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
ES477280A1 (es) Procedimiento para la obtencion de un diastereomero especi- fico de eritro-2-(2-aralquilamino-1-hidroxietil)-1,4-benzo- dioxanos.
ES8704175A1 (es) Un procedimiento para la preparacion de derivados de benzopirano (2,3-d) triazol.
DK0555283T3 (da) Mellemprodukter ved fremstillingen af 4,5-difluoranthranilinsyre
FI863897A (fi) Kemiskt foerfarande.
AR241406A1 (es) Metodo para la preparacion de derivados amino alcanolicos aromaticos policiclicos.
JPS53108981A (en) Thioisocarbostyril derivative and its preparation